ArticlePloS one2024

Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative docetaxel, cisplatin plus 5-fluorouracil treatment (PENTAGON trial).

Hironobu Goto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.